Intralipid

Soybean oil, the active ingredient in Intralipid, is a parenteral nutrition lipid emulsion presented as an emulsion for intravenous infusion use. It provides essential fatty acids and calories for patients who cannot receive enteral feeding and is used to prevent essential fatty acid deficiency in long‑term parenteral therapy.

GNH USA supplies Intralipid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across all markets through rigorous quality assurance.

Intralipid is employed in parenteral nutrition to meet caloric and essential fatty acid requirements in patients unable to receive enteral feeding. Parenteral nutrition: supplies calories and essential fatty acids when oral or tube feeding is not possible Essential fatty acid deficiency: prevents or treats deficiency in long‑term parenteral therapy Caloric supplementation: provides additional energy for critically ill patients requiring increased metabolic support

Intralipid may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Hypertriglyceridemia: elevated serum triglyceride levels during therapy - Fever: transient temperature rise after infusion - Headache: mild to moderate discomfort - Nausea: occasional gastrointestinal upset

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate intervention - Fat overload syndrome: excessive lipid accumulation leading to organ dysfunction - Pulmonary embolism: lipid emboli causing respiratory compromise

When using Intralipid, clinicians should observe specific precautions to minimize risks and ensure optimal therapy. Patient monitoring: regularly check serum triglyceride and liver function levels Infusion rate: adhere to recommended rates to avoid hyperlipidemia and fat overload Allergy assessment: screen for soy or egg protein hypersensitivity before initiation Liver function: monitor patients with hepatic impairment closely Compatibility: avoid mixing with incompatible intravenous solutions Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake

Intralipid can interact with certain medications, affecting lipid metabolism or infusion safety.

Major Interactions (Avoid): - Heparin: may increase risk of hypertriglyceridemia - Propofol: additive lipid load can precipitate fat overload syndrome - Corticosteroids: synergistic increase in serum triglycerides

Moderate Interactions (Monitor Closely): - Beta‑adrenergic agonists: may alter lipid metabolism and affect triglyceride levels - Diuretics: can modify fluid balance during lipid infusion, requiring careful monitoring